Literature DB >> 10470078

Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice.

F Zheng1, G C Kundu, Z Zhang, J Ward, F DeMayo, A B Mukherjee.   

Abstract

The molecular mechanism(s) of immunoglobulin A (IgA) nephropathy, the most common primary renal glomerular disease worldwide, is unknown. Its pathologic features include hematuria, high levels of circulating IgA-fibronectin (Fn) complexes, and glomerular deposition of IgA, complement C3, Fn and collagen. We report here that two independent mouse models (gene knockout and antisense transgenic), both manifesting deficiency of an anti-inflammatory protein, uteroglobin (UG), develop almost all of the pathologic features of human IgA nephropathy. We further demonstrate that Fn-UG heteromerization, reported to prevent abnormal glomerular deposition of Fn and collagen, also abrogates both the formation of IgA-Fn complexes and their binding to glomerular cells. Moreover, UG prevents glomerular accumulation of exogenous IgA in UG-null mice. These results define an essential role for UG in preventing mouse IgA nephropathy and warrant further studies to determine if a similar mechanism(s) underlies the human disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10470078     DOI: 10.1038/12458

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  15 in total

1.  Uteroglobin deficient mice-a novel animal model for IgA nephropathy?

Authors:  S Pouria; S J Challacombe
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

Review 2.  Dysfunctions of the Iga system: a common link between intestinal and renal diseases.

Authors:  Christina Papista; Laureline Berthelot; Renato C Monteiro
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

3.  Development of immunoglobulin A nephropathy- like disease in beta-1,4-galactosyltransferase-I-deficient mice.

Authors:  Toshikazu Nishie; Osamu Miyaishi; Haruhito Azuma; Akihiko Kameyama; Chie Naruse; Noriyoshi Hashimoto; Hitoshi Yokoyama; Hisashi Narimatsu; Takashi Wada; Masahide Asano
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

Review 4.  New insights into the pathogenesis of IgA nephropathy.

Authors:  Jürgen Floege; Ivan C Moura; Mohamed R Daha
Journal:  Semin Immunopathol       Date:  2014-01-18       Impact factor: 9.623

5.  Alleviation of lung inflammatory responses by adeno-associated virus 2/9 vector carrying CC10 in OVA-sensitized mice.

Authors:  Chia-Jen Wu; Li-Chen Chen; Wen-Chung Huang; Chang-Lin Chuang; Ming-Ling Kuo
Journal:  Hum Gene Ther       Date:  2012-11-14       Impact factor: 5.695

6.  Protective role for club cell secretory protein-16 (CC16) in the development of COPD.

Authors:  Maria E Laucho-Contreras; Francesca Polverino; Kushagra Gupta; Katherine L Taylor; Emer Kelly; Victor Pinto-Plata; Miguel Divo; Naveed Ashfaq; Hans Petersen; Barry Stripp; Aprile L Pilon; Yohannes Tesfaigzi; Bartolome R Celli; Caroline A Owen
Journal:  Eur Respir J       Date:  2015-02-19       Impact factor: 16.671

7.  Analysis of a uteroglobin gene polymorphism in childhood Henoch-Schonlein purpura.

Authors:  Eli M Eisenstein; Moonsuk Choi
Journal:  Pediatr Nephrol       Date:  2006-04-20       Impact factor: 3.714

8.  Uteroglobin interacts with the heparin-binding site of fibronectin and prevents fibronectin-IgA complex formation found in IgA-nephropathy.

Authors:  Bhabadeb Chowdhury; Zhongjian Zhang; Anil B Mukherjee
Journal:  FEBS Lett       Date:  2008-02-01       Impact factor: 4.124

9.  Uteroglobin gene polymorphism (G38A) may be a risk factor in childhood idiopathic nephrotic syndrome.

Authors:  Beltinge Demircioglu Kılıc; Mithat Buyukcelik; Sibel Oguzkan Balcı; Sacide Pehlivan; Seval Kul; Nilgun Col; Ayse Balat
Journal:  Pediatr Nephrol       Date:  2017-09-30       Impact factor: 3.714

Review 10.  Are there animal models of IgA nephropathy?

Authors:  Renato C Monteiro; Yusuke Suzuki
Journal:  Semin Immunopathol       Date:  2021-07-07       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.